Table 1.
Study | EV source | Animal model | Ml model | Cardioprotective effects | Mechanism |
---|---|---|---|---|---|
(Timmers et al., 2007) | MSC | Pig | IRI |
|
|
(Timmers et al., 2011) | MSC | Pig | Permanent ligation |
|
|
(Arslan et al., 2013) | MSC | Mouse | IRI |
|
|
(Fang et al., 2014) | IPC MSC | Mouse | Permanent ligation |
|
|
(Teng et al., 2015) | MSC | Rat | Permanent ligation |
|
|
(Kang et al., 2015) | CXCR4 MSC | Rat | Permanent ligation |
|
|
(Yu et al., 2015) | GATA-4 MSC | Rat | Permanent ligation |
|
|
(Liu et al., 2017) | MSC | Rat | IRI |
|
|
(Zhu et al., 2018b) | Hypoxic MSC | Mouse | Permanent ligation |
|
|
(Zhu et al., 2018a) | Hypoxic MSC | Mouse | Permanent ligation |
|
|
(Barile et al., 2014) | CPC | Rat | Permanent ligation |
|
|
(Gray et al., 2015) | Hypoxic CPC | Rat | IRI |
|
|
(Ibrahim et al., 2014) | CDC | Mouse | Permanent ligation |
|
|
(de Couto et al., 2017) | CDC | Rat, Pig | IRI |
|
|
Table 1. Mesenchymal stromal cell, MSC; cardiac progenitor cell, CPC; cardiosphere derived cells, CDC; ischemic preconditioning, IPC; ischemia/reperfusion injury, IRI; Cardiomyocyte, CM; Chemokine receptor 4, CXCR4; Macrophage, Mφ; Micro RNA, miR.